Peer-reviewed veterinary case report
Tight junction protein changes in dog skin with atopic dermatitis
By Kim, Ha-Jung et al.·Published in Veterinary dermatology·2016·Department of Small Animal Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A comparative study of epidermal tight junction proteins in a dog model of atopic dermatitis.
- Species:
- dog
Plain-English summary
A group of beagle dogs with atopic dermatitis (a skin allergy condition) showed lower levels of certain proteins that help keep their skin barrier strong compared to normal dogs. Specifically, the proteins ZO-1 and occludin were found to be significantly reduced in the dogs with skin allergies. This suggests that these proteins might be important in understanding how skin allergies develop in dogs. More research is needed to see how these findings could help treat or manage skin allergies in pets.
People also search for: dog skin allergy treatment · beagle atopic dermatitis symptoms · why is my dog itching
Abstract
BACKGROUND: Tight junctions (TJ) are important for skin barrier function and could be relevant in modulating allergen penetration in atopic dermatitis (AD). Humans with AD have been described to have decreased expressions of some TJ proteins in the skin. HYPOTHESIS/OBJECTIVES: This study aimed to investigate TJ protein expression using an experimental AD model in dogs. METHODS: Skin biopsies from six atopic (nonlesional skin) and five normal beagle dogs were stained for TJ proteins [zonula occludens 1 (ZO-1), occludin, claudin-1] by immunohistochemistry. Staining intensity was evaluated both objectively using imaging software and subjectively. Six images/sections were randomized and blindly scored by six investigators for intensity, distribution, integrity and staining pattern. RESULTS: The intensity of ZO-1 was significantly decreased in the atopic group objectively (P = 0.010) and subjectively (P = 0.002) relative to the normal group. Occludin was decreased significantly subjectively (P = 0.027) but not objectively. Claudin was not significantly different between groups by either quantification. Additionally, only ZO-1 demonstrated a significantly patchier staining pattern in the atopic group. There was no consistent staining pattern in this study. CONCLUSIONS AND CLINICAL IMPORTANCE: ZO-1 and occludin, which have not been described to be associated with the development of AD in humans, could play a role in this atopic dog model. Further investigation on the expression and modulation of TJ proteins and their clinical relevance is needed.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26663564/